These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27497110)

  • 1. Long-term clinical outcome of titanium-nitride-oxide-coated stents versus everolimus-eluting stents in acute coronary syndrome: Final report of the BASE ACS trial.
    Karjalainen PP; Nammas W; Ylitalo A; de Bruyne B; Lalmand J; de Belder A; Rivero-Crespo F; Kervinen K; Airaksinen JKE
    Int J Cardiol; 2016 Nov; 222():275-280. PubMed ID: 27497110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE ACS randomized controlled trial: Bioactive versus everolimus-eluting stents in elderly patients.
    Nammas W; de Belder A; Niemelä M; Sia J; Romppanen H; Laine M; Karjalainen PP
    Eur J Intern Med; 2017 Jan; 37():43-48. PubMed ID: 27499178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of early percutaneous coronary intervention in diabetic patients with acute coronary syndrome: insights from the BASE ACS trial.
    Karjalainen PP; Airaksinen JK; de Belder A; Romppanen H; Kervinen K; Sia J; Laine M; Nammas W
    Ann Med; 2016 Aug; 48(5):376-83. PubMed ID: 27238465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Year outcome of bioactive stents versus everolimus-eluting stents in acute coronary syndrome.
    Karjalainen PP; Niemelä M; Pietilä M; Sia J; de Belder A; Rivero-Crespo F; de Bruyne B; Nammas W
    Scand Cardiovasc J; 2016 Aug; 50(4):218-23. PubMed ID: 27102382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: long-term follow-up from the TITAX AMI trial.
    Tuomainen PO; Ylitalo A; Niemelä M; Kervinen K; Pietilä M; Sia J; Nyman K; Nammas W; Airaksinen KE; Karjalainen PP
    Int J Cardiol; 2013 Sep; 168(2):1214-9. PubMed ID: 23218575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of ST-elevation myocardial infarction versus non-ST-elevation acute coronary syndrome treated with titanium-nitride-oxide-coated versus everolimus-eluting stents: insights from the BASE-ACS trial.
    Romppanen H; Nammas W; Kervinen K; Mikkelsson J; Pietilä M; Lalmand J; Rivero-Crespo F; Pentikäinen M; Tedjokusumo P; Karjalainen PP
    Minerva Cardioangiol; 2013 Apr; 61(2):201-9. PubMed ID: 23492603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Preexisting Vascular Disease on the Outcome of Patients With Acute Coronary Syndrome: Insights From the Comparison of Bioactive Stent to the Everolimus-Eluting Stent in Acute Coronary Syndrome Trial.
    Nammas W; Airaksinen JKE; Romppanen H; Sia J; de Belder A; Karjalainen PP
    Angiology; 2017 Jul; 68(6):513-518. PubMed ID: 27543565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Titanium-Nitride-Oxide-Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome: The Randomized TIDES-ACS Trial.
    Tonino PAL; Pijls NHJ; Collet C; Nammas W; Van der Heyden J; Romppanen H; Kervinen K; Airaksinen JKE; Sia J; Lalmand J; Frambach P; Penaranda AS; De Bruyne B; Karjalainen PP;
    JACC Cardiovasc Interv; 2020 Jul; 13(14):1697-1705. PubMed ID: 32703593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective randomised comparison of titanium-nitride-oxide-coated bioactive stents with everolimus-eluting stents in acute coronary syndrome: the BASE-ACS trial.
    Karjalainen PP; Niemelä M; Airaksinen JK; Rivero-Crespo F; Romppanen H; Sia J; Lalmand J; de Bruyne B; Debelder A; Carlier M; Nammas W; Ylitalo A; Hess OM;
    EuroIntervention; 2012 Jul; 8(3):306-15. PubMed ID: 22829506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-based analysis of randomized comparison of bioactive versus everolimus-eluting stents in acute coronary syndrome.
    Sia J; Nammas W; Niemelä M; Airaksinen JK; Lalmand J; Laine M; Tedjokusumo P; Nyman K; Biancari F; Karjalainen PP
    J Cardiovasc Med (Hagerstown); 2015 Mar; 16(3):197-203. PubMed ID: 25003998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of Post-coronary Dilation to Prevent Recurrent Myocardial Infarction in Patients Treated With Percutaneous Coronary Intervention for Acute Coronary Syndrome (from the BASE ACS Trial).
    Karjalainen PP; Niemelä M; Laine M; Airaksinen JK; Ylitalo A; Nammas W
    Am J Cardiol; 2017 Feb; 119(3):345-350. PubMed ID: 27887689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stent-oriented versus patient-oriented outcome in patients undergoing early percutaneous coronary intervention for acute coronary syndrome: 2-year report from the BASE-ACS trial.
    Romppanen H; Nammas W; Kervinen K; Airaksinen JK; Pietilä M; Rivero-Crespo F; Debelder A; Tedjokusumo P; Mikkelsson J; Ylitalo A; Karjalainen PP
    Ann Med; 2013 Nov; 45(7):488-93. PubMed ID: 24032547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial.
    Karjalainen P; Kiviniemi TO; Lehtinen T; Nammas W; Ylitalo A; Saraste A; Mikkelsson J; Pietila M; Biancari F; Airaksinen JK
    Int J Cardiovasc Imaging; 2013 Dec; 29(8):1693-703. PubMed ID: 23996244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography follow-up 18 months after titanium-nitride-oxide-coated versus everolimus-eluting stent implantation in patients with acute coronary syndrome.
    Karjalainen P; Paana T; Ylitalo A; Sia J; Nammas W
    Acta Radiol; 2017 Sep; 58(9):1077-1084. PubMed ID: 28273737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Titanium-Nitride-Oxide-Coated vs Everolimus-Eluting Stents in Acute Coronary Syndrome: 5-Year Clinical Outcomes of the TIDES-ACS Randomized Clinical Trial.
    Bouisset F; Sia J; Mizukami T; Karjalainen PP; Tonino PAL; Pijls NHJ; Van der Heyden J; Romppanen H; Kervinen K; Airaksinen JKE; Lalmand J; Frambach P; Roza da Costa B; Collet C; De Bruyne B;
    JAMA Cardiol; 2023 Jul; 8(7):703-708. PubMed ID: 37203243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early vascular healing after titanium-nitride-oxide-coated stent versus platinum-chromium everolimus-eluting stent implantation in patients with acute coronary syndrome.
    Varho V; Kiviniemi TO; Nammas W; Sia J; Romppanen H; Pietilä M; Airaksinen JK; Mikkelsson J; Tuomainen P; Perälä A; Karjalainen PP
    Int J Cardiovasc Imaging; 2016 Jul; 32(7):1031-9. PubMed ID: 27076220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Calcified Target Lesions on the Outcome of Percutaneous Coronary Intervention for Acute Coronary Syndrome: Insights From the BASE ACS Trial.
    Karjalainen PP; Nammas W; Kervinen K; de Belder A; Rivero-Crespo F; Ylitalo A; Airaksinen JK
    J Interv Cardiol; 2017 Apr; 30(2):114-123. PubMed ID: 27925308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
    Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) Trials.
    Planer D; Smits PC; Kereiakes DJ; Kedhi E; Fahy M; Xu K; Serruys PW; Stone GW
    JACC Cardiovasc Interv; 2011 Oct; 4(10):1104-15. PubMed ID: 22017936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revascularization in Daily Practice).
    Smits PC; Vlachojannis GJ; McFadden EP; Royaards KJ; Wassing J; Joesoef KS; van Mieghem C; van de Ent M
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1157-1165. PubMed ID: 26210806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.